Publication Name	World Journal of Hepatology
Manuscript ID	84673
Country	China

Received	2023-03-23 15:39
Peer-Review Started	2023-03-23 15:42
To Make the First Decision
Return for Revision	2023-05-15 08:17
Revised	2023-06-11 09:59
Second Decision	2023-06-29 02:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-06-30 03:52
Articles in Press	2023-06-30 03:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-07-04 01:08
Publish the Manuscript Online	2023-07-21 09:10

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Microbiology
Manuscript Type	Review
Article Title	Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications
Manuscript Source	Invited Manuscript
All Author List	Gong-Jing Guo, Fei Yao, Wei-Peng Lu and Hao-Ming Xu
ORCID	Author(s) ORCID Number Gong-Jing Guo http://orcid.org/0009-0009-3249-3202 Fei Yao http://orcid.org/0009-0006-5993-4774 Wei-Peng Lu http://orcid.org/0009-0000-6847-5940 Hao-Ming Xu http://orcid.org/0000-0002-8131-7477
Funding Agency and Grant Number	Funding Agency Grant Number Guangzhou Planned Project of Science and Technology 2023A04J0612
Corresponding Author	Hao-Ming Xu, Doctor, MD, Doctor, Department of Gastroenterology and Hepatology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China, 1Panfu Load, Guangzhou 510180, Guangdong Province, China. haomingxu1992@126.com
Key Words	Metabolic-associated fatty liver disease; Gut microbiota; Current status; Application
Core Tip	Metabolic-associated fatty liver disease (MAFLD) is a highly prevalent metabolic disease worldwide. In this review, we provide an overview of the current status and potential applications of the gut microbiota (GM) in MAFLD, focusing on key aspects such as bile acid circulation, energy metabolism, and microelement disorder, as well as signal pathways and GM metabolites implicated in MAFLD development and treatments, with a particular emphasis on targeting the microbiome.
Publish Date	2023-07-21 09:10
Citation	Guo GJ, Yao F, Lu WP, Xu HM. Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications. World J Hepatol 2023; 15(7): 867-882
URL	https://www.wjgnet.com/1948-5182/full/v15/i7/867.htm
DOI	https://dx.doi.org/10.4254/wjh.v15.i7.867

Full Article (PDF)	WJH-15-867-with-cover.pdf
Full Article (Word)	WJH-15-867.docx
Manuscript File	84673_Auto_Edited-LJH-JLW.docx
Answering Reviewers	84673-Answering reviewers.pdf
Audio Core Tip	84673-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	84673-Conflict-of-interest statement.pdf
Copyright License Agreement	84673-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	84673-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	84673-Language certificate.pdf
Peer-review Report	84673-Peer-review(s).pdf
Scientific Misconduct Check	84673-Bing-Liu JH-2.png
Scientific Misconduct Check	84673-CrossCheck.png
Scientific Editor Work List	84673-Scientific editor work list.pdf